{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T04:10:05Z","timestamp":1719807005049},"reference-count":7,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.amjms.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T07:58:29Z","timestamp":1518422309000},"page":"615-616","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["About a Suggestive Association Between Fanconi Anemia and Laron Syndrome"],"prefix":"10.1016","volume":"355","author":[{"given":"I.","family":"Castilla-Cortazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"De Ita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.amjms.2018.02.004_bib1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4158\/EP15939.RA","article-title":"Lesson from 50 years of study of Laron syndrome","volume":"21","author":"Laron","year":"2015","journal-title":"Endocr Pr"},{"key":"10.1016\/j.amjms.2018.02.004_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/biof.1255","article-title":"Partial IGF-1 deficiency induces brain oxidative damage and edema, which are ameliorated by replacement therapy","volume":"42","author":"Puche","year":"2016","journal-title":"Biofactors"},{"issue":"2","key":"10.1016\/j.amjms.2018.02.004_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13105-016-0545-x","article-title":"IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture","volume":"73","author":"Lara-Diaz","year":"2017","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.amjms.2018.02.004_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-017-1198-4","article-title":"Experimental approach to IGF-1 therapy in CCl<inf>4<\/inf>-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency","volume":"15","author":"Morales-Garza","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.amjms.2018.02.004_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd917","article-title":"Structural biology of insulin and IGF1 receptors: implications for drug design","volume":"1","author":"De Meyts","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.amjms.2018.02.004_bib6","series-title":"Endocrine Society\u2032s 98th Annual Meeting and Expo","article-title":"novel dominant-negative STAT5B mutations associated with growth hormone insensitivity and severe short stature: expanding the clinical spectrum of STAT5B deficiency","author":"Gevers","year":"2016"},{"key":"10.1016\/j.amjms.2018.02.004_bib7","doi-asserted-by":"crossref","first-page":"E1896","DOI":"10.1210\/jc.2011-1597","article-title":"The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects","volume":"96","author":"Derr","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918300569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918300569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T03:54:03Z","timestamp":1719806043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962918300569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0002962918300569"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2018.02.004","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"About a Suggestive Association Between Fanconi Anemia and Laron Syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2018.01.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}